FDA Issues Warning for DPP-4 Inhibitors; published in ClevelanD Clinic
on 08.09.2015, drugs like sitagliptin, saxagliptin, linagliptin, and
alogliptin, used to treat Type 2 Diabetes Mellitus, may cause joint pain
that can be severe and disabling. Nevertheless, FDA has not advised to
stop the medications.
...
Click here to Subscribe news feed from "Clinicianonnet; so that you do not miss out anything that can be valuable to you !!
...
Posts
